Activation of Wnt/β-catenin signaling is critical for the tumorigenesis of choroid plexus

Investor logo

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

HO Kim Hoa TRAPP Marleen GUIDA Catello IVANOVA Ekaterina L ANCHEL De Jaime-Soguero JABALI Ammar THOMAS Christian SALASOVA Alena BERNATÍK Ondřej SALIO Chiara HORSCHITZ Sandra HASSELBLATT Martin SASSOE-POGNETTO Marco ČAJÁNEK Lukáš ISHIKAWA Hiroshi SCHROTEN Horst SCHWERK Christian ACEBRON Sergio P ANGEL Peter KOCH Philipp PATRIZI Annarita

Year of publication 2024
Type Article in Periodical
Magazine / Source Neuro-Oncology
MU Faculty or unit

Faculty of Medicine

Citation
Web https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noae176/7746517?login=true
Doi http://dx.doi.org/10.1093/neuonc/noae176
Keywords APC; brain tumor; choroid plexus organoid; rare childhood cancer; Wnt signaling
Description Background. The choroid plexus (ChP) is the secretory epithelial structure located in the brain ventricles. Choroid plexus tumors (CPTs) are rare neoplasms predominantly occurring in young patients with intensified malignancy in children. CPT treatment is hindered by insufficient knowledge of tumor pathology and the limited availability of valid models. Methods. Genomic and transcriptomic data from CPT patients were analyzed to identify the putative pathological pathway. Cellular and molecular techniques were employed to validate bioinformatic results in CPT patient samples. Pharmacologic inhibition of Wnt/beta-catenin signaling was assessed in CPT cells. Cell-based assays of ChP cell lines were performed following CRISPR-Cas9-derived knockout and overexpression of Wnt/beta-catenin pathway genes. A 3D CPT model was generated through CRISPR-Cas9-derived knockout of APC. Results. We discovered that Wnt/beta-catenin signaling is activated in human CPTs, likely as a consequence of large-scale chromosomal instability events of the CPT genomes. We demonstrated that CPT-derived cells depend on autocrine Wnt/beta-catenin signaling for survival. Constitutive Wnt/beta-catenin pathway activation, either through knockout of the negative regulator APC or overexpression of the ligand WNT3A, induced tumorigenic properties in ChP 2D in vitro models. Increased activation of the Wnt/beta-catenin pathway in ChP organoids, through treatment with a potent GSK3 beta inhibitor, reduced the differentiation of mature ChP epithelial cells. Remarkably, the depletion of APC was sufficient to induce the oncogenic transformation of ChP organoids. Conclusions. Our research identifies Wnt/beta-catenin signaling as a critical driver of CPT tumorigenesis and provides the first 3D in vitro model for future pathological and therapeutic studies of CPT.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info